Hemiasterlin derivatives and uses thereof

Details Hemiasterlin derivatives and uses thereof Hemiasterlin derivatives and uses thereof

2007-03-20

2007-03-20

McKane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S245000

Reexamination Certificate

active

10508607

ABSTRACT:
The present invention provides compounds having formula (I):and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1–R7, X1, X2, R, Q, and n are as defined herein.

REFERENCES:
patent: 5661175 (1997-08-01), Kashman et al.
patent: 6057297 (2000-05-01), Politi et al.
patent: 6143721 (2000-11-01), Janssen et al.
patent: 6153590 (2000-11-01), Andersen et al.
patent: 40 16 994 (1991-11-01), None
patent: 8-73444 (1996-03-01), None
patent: WO 96/33211 (1996-10-01), None
patent: WO 97/43305 (1997-11-01), None
patent: WO 98/13375 (1998-04-01), None
patent: WO-99/31122 (1999-06-01), None
patent: WO 99/31122 (1999-06-01), None
patent: WO 99/32509 (1999-07-01), None
patent: WO 99/65299 (1999-12-01), None
patent: WO 01/18032 (2001-03-01), None
patent: WO 01/79167 (2001-10-01), None
patent: WO 03/008378 (2003-01-01), None
patent: WO 04/47615 (2004-06-01), None
patent: WO 04/48527 (2004-06-01), None
Bhatnager et al., STN International, HCAPLUS Database, Columbus, OH, Accession No. 1999:811016 (2006).
Kovacs et al., “Antiamnesic effects of D-pipecolic acid and analogs of Pro-Leu-Gly-NH2 in rats,” Pharmacology, Biochemistry and Behavior, vol. 31(4), p. 833-7 (1998).
Szabo et al., “Effects of oxytocin fragment and its analogs on brain monoamine levels in rat brains,” Neuropept. Psychosom. Processes, Int. Conf. Integr. Neurohumoral Mech. (1983), Meeting Date 1982, 195-200.
Szabo et al., STN International, HCAPLUS Database, Columbus, OH, Accession No. 1985:179250 (2006).
Politi et al., STN International, HCAPLUS Database, Columbus, OH, Accession No. 1997:244196 (2006).
Kovacs et al., STN International, HCAPLUS Database, Columbus, OH, Accession No. 1989:400176 (2006).
U.S. Appl. No. 10/667,864, filed Sep. 22, 2003, Kowalczyk, et al.
Anderson, et al., “Total Synthesis of (-) Hemiasterlin, A Structurally Novel Tripeptide that Exhibits Potent Cytotoxic Activity”,Tetrahedron Letters, 38(3): 317-320, 1997.
Billson, et al., “The Design and Synthesis of Inhibitors of the Cysteinyl Protease, Der P I.”,Bioorganic&Medicinal Chemistry Letters, 8: 993-998, 1998.
Dragovich, et al., “Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure-Activity Studies”,J. Med. Chem. 41: 2806-2818, 1998.
Hauske, et al., “Design and Synthesis of Novel FKBP Inhibitors”,J. Med. Chem. 35: 4284-4296, 1992.
Nieman, et al., “Synthesis and Antimitotic/Cytotoxic Activity of Hemiasterlin Analogues”,J. Nat. Prod. 66: 183-189, 2003.
International Search Report for PCT/US03/08888 (2004).
Jones, et al., “The use of norbornene derivatives in the synthesis of conformationally constrained peptides and pseudo-peptides”,Letters in Peptide Science, 5(2-3): 171-173, 1998.
Partial International Search Report for related International Application No. PCT/US04/30921 (2005).

Affiliated with

Also associated with

Rating

Hemiasterlin derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hemiasterlin derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemiasterlin derivatives and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3731516